Performance of Zr-Based Metal–Organic Framework Materials as In Vitro Systems for the Oral Delivery of Captopril and Ibuprofen
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241813887 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Carmen Cretu und 9 weiteren Autor:innen. Beteiligte Einrichtung: "Coriolan Drăgulescu" Institute of Chemistry, Bv. Mihai Viteazu, No. 24, 300223 Timisoara, Romania. Hauptthemen laut MEDLINE: Zirconium, Ibuprofen, Metal-Organic Frameworks, Captopril. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Zr-based metal–organic framework materials (Zr-MOFs) with increased specific surface area and pore volume were obtained using chemical (two materials, Zr-MOF1 and Zr-MOF3) and solvothermal (Zr-MOF2) synthesis methods and investigated via FT-IR spectroscopy, TGA, SANS, PXRD, and SEM methods. The difference between Zr-MOF1 and Zr-MOF3 lies in the addition of reactants during synthesis. Nitrogen porosimetry data indicated the presence of pores with average dimensions of ~4 nm; using SANS, the average size of the Zr-MOF nanocrystals was suggested to be approximately 30 nm. The patterns obtained through PXRD were characterized by similar features that point to well-crystallized phases specific for the UIO-66 type materials; SEM also revealed that the materials were composed of small and agglomerate crystals. Thermogravimetric analysis revealed that both materials had approximately two linker deficiencies per Zr6 formula unit. Captopril and ibuprofen loading and release experiments in different buffered solutions were performed using the obtained Zr-based metal–organic frameworks as drug carriers envisaged for controlled drug release. The carriers demonstrated enhanced drug-loading capacity and showed relatively good results in drug delivery. The cumulative percentage of drug release in phosphate-buffered solution at pH 7.4 was higher than that in buffered solution at pH 1.2. The release rate could be controlled by changing the pH of the releasing solution. Different captopril release behaviors were observed when the experiments were performed using a permeable dialysis membrane.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- "Coriolan Drăgulescu" Institute of Chemistry, Bv. Mihai Viteazu, No. 24, 300223 Timisoara, Romania.
- Biology-Chemistry Department, West University of Timisoara, Johann Heinrich Pestalozzi No. 16, 300115 Timisoara, Romania.
- Institute for Energy Security and Environmental Safety, Centre for Energy Research, Konkoly-Thege Miklós Út 29-33, 1121 Budapest, Hungary.
- Faculty of Engineering and Information Technology, University of Pécs, Boszorkány Street 2, 7624 Pécs, Hungary.
- Institute for Technical Physics and Material Science, Centre for Energy Research, Konkoly-Thege Út 29-33, 1121 Budapest, Hungary.
ORCID-Profile: Sorin-Alin Marinescu, Mariana Suba, Ana-Maria Putz
Zitieren
APA
Cretu, C., Nicola, R., Marinescu, S. A., Picioruș, E. M., Suba, M., Duda-Seiman, C., Len, A., Illés, L., Horváth, Z. E., & Putz, A. M. (2023). Performance of Zr-Based Metal–Organic Framework Materials as In Vitro Systems for the Oral Delivery of Captopril and Ibuprofen. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241813887
Vancouver
Cretu C, Nicola R, Marinescu SA, Picioruș EM, Suba M, Duda-Seiman C, et al. Performance of Zr-Based Metal–Organic Framework Materials as In Vitro Systems for the Oral Delivery of Captopril and Ibuprofen. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241813887
BibTeX
@article{Cretu2023,
author = {Cretu, Carmen and Nicola, Roxana and Marinescu, Sorin-Alin and Picioruș, Elena-Mirela and Suba, Mariana and Duda-Seiman, Corina and Len, Adel and Illés, Levente and Horváth, Zsolt Endre and Putz, Ana-Maria},
title = {Performance of Zr-Based Metal–Organic Framework Materials as In Vitro Systems for the Oral Delivery of Captopril and Ibuprofen},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241813887}
}
EUVIMED